Iroxanadine (hydrobromide)
Iroxanadine hydrobromide (BRX 005) is a vasculoprotector. Iroxanadine is a p38 kinase and HSP protein dual activator. Iroxanadine hydrobromide has the potential for atherosclerosis and vascular diseases research[1].
Product Specifications
CAS Number
276690-62-1
Product Name Alternative
(-) -BRX 005 (hydrobromide) ; (-) -BRX 235 (hydrobromide)
UNSPSC
12352005
Target
HSP; p38 MAPK
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; MAPK/ERK Pathway; Metabolic Enzyme/Protease
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/iroxanadine-hydrobromide.html
Smiles
C1(C2=CC=CN=C2)=NOCC(CN3CCCCC3)N1.Br
Molecular Formula
C14H21BrN4O
Molecular Weight
341.25
References & Citations
[1]Denes L, et al. Reverse regulation of endothelial cells and myointimal hyperplasia on cell proliferation by a heatshock protein-coinducer after hypoxia. Stroke. 2008 Mar;39 (3) :1022-4.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TP721869 50 µg
CCR3 Human Recombinant Protein, Membrane Nanoparticle
Sign In for Pricing
View Details 
LY419982 100 µg
DNase II (DNASE2) (NM_001375) Human Over-expression Lysate
Sign In for Pricing
View Details 
